Patients’ health and wellbeing is being put at risk by the federal government’s refusal to enact protection of the word ‘physio’, which can be – and frequently is – used by non-physiotherapist practitioners.
While AHPRA's crackdown on the misleading use of health practitioners' "protected titles" by untrained or inappropriately trained individuals has been widely lauded, it seems one speciality has slipped through the net.
Last November the Australian Physiotherapy Association (APA) called on the Federal Government to protect the title ‘physio’ in line with the protected status of ‘physiotherapist’ and ‘physiotherapy’, giving the public assurance that any practitioners using these titles are fully qualified, registered physiotherapists using evidence-informed treatments. This issue is now more pressing than ever, following the announcement by AHPRA that tougher sanctions have come into force for people falsely claiming to be a registered health practitioner.
Early access to specialist lymphedema physiotherapy treatment should be funded by the government, according to the Australian Physiotherapy Association, who joined the Australian Lymphology Association in calling for change.
The launch of the National Strategic Action Plan for Arthritis this week outlines a clear pathway to implement affordable, timely access to services - including properly funded physiotherapy treatment - to support the four million Australians who live with arthritis, the leading cause of chronic pain in Australia.
Allied health professionals certified with limited registration from their professional body are eligible to provide complex pain management services in residential aged care, the Department of Health has ruled.
The Australian Physiotherapy Association has called on the Government to protect the term ‘physio’, in the same way ‘Physiotherapist’ and ‘Physiotherapy’ are already protected, ensuring that practitioners using these titles are qualified and registered.
The National Osteoarthritis (OA) Strategy was unveiled at the OA Summit in Canberra today, with the aim of combatting the soaring rates of OA in Australia and providing cost effective, evidence-based solutions for the more than 2.2 million Australians living with the debilitating condition.
A leading osteoarthritis expert says too often patients receive fragmented and inappropriate care to manage their damaged joints. Professor David Hunter is leading a national strategy to significantly improve the way patients with osteoarthritis are managed.